Cefaclor: Difference between revisions

Jump to navigation Jump to search
m (Protected "Cefaclor": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
Line 20: Line 20:
}}
}}
{{SI}}
{{SI}}
{{EH}}
 


'''Cefaclor''', also known as '''cefachlor''' or '''cefaclorum''' (brand names '''Ceclor''', '''Distaclor''', '''Keflor''', '''Raniclor'''), is a second-generation [[cephalosporin]] [[antibiotic]] used to treat certain [[infection]]s caused by [[bacteria]] such as [[pneumonia]] and ear, lung, skin, throat, and urinary tract infections.
'''Cefaclor''', also known as '''cefachlor''' or '''cefaclorum''' (brand names '''Ceclor''', '''Distaclor''', '''Keflor''', '''Raniclor'''), is a second-generation [[cephalosporin]] [[antibiotic]] used to treat certain [[infection]]s caused by [[bacteria]] such as [[pneumonia]] and ear, lung, skin, throat, and urinary tract infections.
Line 58: Line 58:


[[Category:Cephalosporin antibiotics]]
[[Category:Cephalosporin antibiotics]]
{{SIB}}
 
[[hu:Cefaclor]]
[[hu:Cefaclor]]
[[pt:Cefaclor]]
[[pt:Cefaclor]]

Revision as of 23:35, 8 August 2012

Cefaclor
File:Cefaclor structure.svg
Clinical data
Pregnancy
category
  • AU: B1
  • US: B (No risk in non-human studies)
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
BioavailabilityWell absorbed, independent of food intake
Metabolism15% to 40%
Elimination half-life0.6 to 0.9 hours
ExcretionRenal
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC15H14ClN3O4S
Molar mass367.808 g/mol

WikiDoc Resources for Cefaclor

Articles

Most recent articles on Cefaclor

Most cited articles on Cefaclor

Review articles on Cefaclor

Articles on Cefaclor in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cefaclor

Images of Cefaclor

Photos of Cefaclor

Podcasts & MP3s on Cefaclor

Videos on Cefaclor

Evidence Based Medicine

Cochrane Collaboration on Cefaclor

Bandolier on Cefaclor

TRIP on Cefaclor

Clinical Trials

Ongoing Trials on Cefaclor at Clinical Trials.gov

Trial results on Cefaclor

Clinical Trials on Cefaclor at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cefaclor

NICE Guidance on Cefaclor

NHS PRODIGY Guidance

FDA on Cefaclor

CDC on Cefaclor

Books

Books on Cefaclor

News

Cefaclor in the news

Be alerted to news on Cefaclor

News trends on Cefaclor

Commentary

Blogs on Cefaclor

Definitions

Definitions of Cefaclor

Patient Resources / Community

Patient resources on Cefaclor

Discussion groups on Cefaclor

Patient Handouts on Cefaclor

Directions to Hospitals Treating Cefaclor

Risk calculators and risk factors for Cefaclor

Healthcare Provider Resources

Symptoms of Cefaclor

Causes & Risk Factors for Cefaclor

Diagnostic studies for Cefaclor

Treatment of Cefaclor

Continuing Medical Education (CME)

CME Programs on Cefaclor

International

Cefaclor en Espanol

Cefaclor en Francais

Business

Cefaclor in the Marketplace

Patents on Cefaclor

Experimental / Informatics

List of terms related to Cefaclor


Cefaclor, also known as cefachlor or cefaclorum (brand names Ceclor, Distaclor, Keflor, Raniclor), is a second-generation cephalosporin antibiotic used to treat certain infections caused by bacteria such as pneumonia and ear, lung, skin, throat, and urinary tract infections.

Indications

Cefaclor belongs to the family of antibiotics known as the cephalosporins (cefalosporins). The cephalosporins are broad-spectrum antibiotics which are used for the treatment of septicaemia, pneumonia, meningitis, biliary-tract infections, peritonitis, and urinary-tract infections. The pharmacology of the cephalosporins is similar to that of the penicillins, excretion being principally renal. Cephalosporins penetrate the cerebrospinal fluid poorly unless the meninges are inflamed; cefotaxime is a more suitable cephalosporin than cefaclor for infections of the central nervous system, e.g meningitis. Cefaclor is active against many bacteria, including both Gram-negative and Gram-positive organisms.

Cautions and contraindications

Cautions include known sensitivity to beta-lactam antibacterials, such as penicillins (Cefaclor should be avoided if there is a history of immediate hypersensitivity reaction); renal impairment (no dose adjustment required, although manufacturer advises caution); pregnancy and breast-feeding (but appropriate to use); false positive urinary glucose (if tested for reducing substances) and false positive Coombs test. Cefaclor has also been reported to cause a serum sickness-like reaction in children.[1][2]

Cefaclor is contraindicated in case of hypersensitivity (i.e. allergy) to cephalosporins.

Side effects

The principal side effect of the cephalosporins is hypersensitivity, and about 10% of penicillin-sensitive patients will also be allergic to the cephalosporins. Allergic reactions may present as, for example, rashes, pruritus (itching), urticaria, serum sickness-like reactions with rashes, fever and arthralgia, and anaphylaxis.

Other side effects include gastrointestinal disturbances (e.g. diarrhea, nausea and vomiting, abdominal discomfort, disturbances in liver enzymes, transient hepatitis and cholestatic jaundice), headache, and Stevens-Johnson syndrome. Rare side effects include eosinophilia and blood disorders (including thrombocytopenia, leucopenia, agranulocytosis, aplastic anaemia and haemolytic anaemia); reversible interstitial nephritis; hyperactivity, nervousness, sleep disturbances, hallucinations, confusion, hypertonia, and dizziness.

Toxic epidermal necrolysis has been reported. In the UK, The Committee on the Safety of Medicines (CSM) has warned that the risk of diarrhea and rarely antibiotic-associated colitis are more likely with higher doses.

Interactions with other medications

Coumarins (e.g. Warfarin): Cephalosporins possibly enhance the anticoagulant effect of coumarins- change in patient's clinical condition, particularly associated with liver disease, intercurrent illness, or drug administration, necessitates more frequent testing of INR, and dose adjustment as necessary. Probenecid: excretion of cephalosporins is reduced by probenecid (resulting in increased concentrations of drug in the blood plasma). Antacids: Absorption of cefaclor is reduced by antacids; therefore antacids should not be taken at the same time as cefaclor.

Safety in pregnancy and breastfeeding

Cefaclor is passed into the breast milk in small quantities, but is generally accepted to be safe to take during breastfeeding. Cefaclor is not known to be harmful in pregnancy, although the potential risk of harm to the fetus must be balanced against the therapeutic benefits to mother and child of the drug.

Dose

Adults: 250 mg every 8 hours, doubled for severe infections, to a maximum of 4 g daily. Children over 1 month: 20 mg/kg daily in 3 divided doses, doubled for severe infections, to a maximum of 1 g daily; or 1 month–1 year, 62.5 mg every 8 hours; 1–5 years, 125 mg; over 5 years, 250 mg; doses doubled for severe infections.

References

  1. Hebert A, Sigman E, Levy M (1991). "Serum sickness-like reactions from cefaclor in children". J Am Acad Dermatol. 25 (5 Pt 1): 805&ndash, 8. PMID 1802903.
  2. Parra F, Igea J, Martín J, Alonso M, Lezaun A, Sainz T (1992). "Serum sickness-like syndrome associated with cefaclor therapy". Allergy. 47 (4 Pt 2): 439&ndash, 40. PMID 1456417.


hu:Cefaclor th:เซฟาคลอร์


Template:WS